Finance

Lists
008930:KRX
Hanmi Science Co Ltd
â‚©44,500.00
+5.70%
(+2,400.00) 1D
Aug 28, 3:30:20 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 008930...
Open
â‚©42,250
High
â‚©44,650
Low
â‚©41,900
Mkt. cap
3.04T
Avg. vol.
398.15K
Volume
0.00
Dividend
0.67%
Quarterly dividend
â‚©75
Ex-dividend date
Mar 30, 2026
P/E ratio
19.97
52-wk high
â‚©57,500
52-wk low
â‚©25,600
EPS
â‚©2,228
Shares outstanding
68.39M
No. of employees
476
Open
â‚©42,250
High
â‚©44,650
Low
â‚©41,900
Mkt. cap
3.04T
Avg. vol.
398.15K
Volume
0.00
Dividend
0.67%
Quarterly dividend
â‚©75
Ex-dividend date
Mar 30, 2026
P/E ratio
19.97
52-wk high
â‚©57,500
52-wk low
â‚©25,600
EPS
â‚©2,228
Shares outstanding
68.39M
No. of employees
476
About Hanmi Science Co Ltd
CEOSong Young-sook
Employees476
Founded1973
HeadquartersSeoul, Songpa District, South Korea
SectorHealth care provider
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
362.10B
285.67B
353.70B
367.86B
Cost of goods sold
-
260.59B
553.49B
-
Cost of revenue
-
260.59B
553.49B
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
322.80B
66.60B
-215.97B
346.53B
Operating expense
322.80B
69.10B
-211.43B
346.53B
Total operating expenses
322.80B
329.69B
342.06B
346.53B
Operating income
39.30B
-44.02B
11.64B
21.32B
Other non operating income
-14.01M
2.88B
-22.70M
-1.36B
EBT including unusual items
37.62B
37.17B
45.33B
56.64B
EBT excluding unusual items
37.57B
38.89B
45.33B
56.64B
Income tax expense
5.74B
4.11B
3.05B
12.98B
Effective tax rate
15.27%
11.05%
6.72%
22.91%
Other operating expenses
-
-
-
-
Net income
32.28B
32.26B
42.71B
43.67B
Net profit margin
8.92%
11.29%
12.07%
11.87%
Earnings per share
-
-
-
-
Interest and investment income
486.63M
510.38M
524.08M
480.98M
Interest expense
-2.56B
-2.59B
-2.81B
-1.91B
Net interest expenses
-2.07B
-2.08B
-2.28B
-1.42B
Depreciation and amortization charges
-
2.50B
4.54B
-
EBITDA
41.59B
-41.51B
13.94B
23.57B
Gain or loss from assets sale
-547.73K
-1.75M
-13.26B
20.00K
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps